policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…
policy
Veterinary ergonomic guidelines
Discover risk factors that could lead to musculo-skeletal injury, examples of related tasks in veterinary medicine, and what to do if you identify a…
policy
Veterinary compounding
Compounding is the customized manipulation of a drug by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs…
Compounding: FAQs for veterinarians
Get answers to the compounding questions veterinarians most frequently ask the AVMA.
Rodenticides: Clinical aspects
Information about rodenticides and rodenticide poisoning for veterinarians and veterinary professionals.
JAVMA news
Scott honored for advancing feline health
Conference exhibits work of animal disease researchers
JAVMA news
Cancer center receives large donation
A family has pledged $10 million to the Colorado State University Flint Animal Cancer Center, which is the single largest contribution in the center’s…
JAVMA news
No ruling coming in compounding dispute
A Florida pharmacy and federal drug authorities have fought for 2 1/2 years over the legality of compounding animal drugs from bulk pharmaceutical…
JAVMA news
Genetically engineering a pet? History shows it won't be easy
A transgenic animal is one whose genome has been altered by the introduction of foreign DNA.